Both exosome therapy and platelet-rich plasma (PRP) therapy are regenerative medicine techniques that aim to stimulate the body’s natural healing process. However, there are some significant differences between the two therapies.

​PRP therapy involves drawing blood from the patient and spinning it in a centrifuge to separate the platelet-rich plasma from the rest of the blood components. The resulting plasma, typically yields between 15 and 25 growth factors.  The plasma  is then injected into the patient’s injured or damaged tissue, promoting the growth of new cells and the repair of damaged tissue.

​Exosome therapy, on the other hand, involves the use of exosomes extracted from donated human mesenchymal stem cells (MSCs). These exosomes contain a rich cocktail of lipids, messenger-RNA, micro-RNA, signaling cytokines, and proteins that are essential for cell-to-cell communication and overall cell health. Our eXosomes have over 700 Growth Factors!  When administered through intravenous (IV) therapy or direct injection, exosomes can help restore and revitalize target cells throughout the body.

​While both therapies have been shown to be effective, exosome therapy offers several unique benefits. One of the main advantages of exosome therapy is the ability to deliver a high concentration of growth factors and other beneficial components to the injured or damaged tissue without introducing any foreign substances into the body. Additionally, exosomes are capable of crossing the blood-brain barrier, making them an effective treatment for neurological conditions.

Another significant advantage of exosome therapy is that it can be administered repeatedly without risk of immune rejection or infection, unlike PRP therapy. Furthermore, exosome therapy has shown promise in the treatment of a wide range of conditions, including joint pain, neurodegenerative disorders, and autoimmune diseases, whereas PRP therapy is mainly used for musculoskeletal injuries and arthritis.